Skip to main content
. 2013 Sep 7;19(33):5485–5492. doi: 10.3748/wjg.v19.i33.5485

Figure 1.

Figure 1

Evaluation by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay of pancreatic cancer MIA-PaCa-2 cell viability after propofol pretreatment. A: Cells were either untreated or treated with 10-100 μmol/mL propofol for 72 h; B: Cells treated with 100 μmol/mL propofol for 24, 48, or 72 h. aP < 0.05 vs control group.